BioStone Animal Health Launches Real-Time PCR tests for FMD Detection

DALLAS-FORT WORTH, TX— May 30, 2025 — BioStone Animal Health is proud to announce a comprehensive solution for Foot-and-Mouth Disease (FMD) diagnostics with the launch of new real-time (RT) PCR assays.

The newly introduced AsurDxTM Real-Time PCR kits include single, dual, and multiplex detection options for:.

This product line complements BioStone’s existing portfolio of competitive ELISA (cELISA) kits for serotype-specific detection of FMDV antibodies in serum, including:

The AsurDXTM Real-Time PCR kits are designed for quantitative detection of FMD viral genes and feature a user-friendly, standardized workflow across test types. Each kit includes all required reagents and controls, is compatible with a wide range of thermal cyclers, and uses pre-validated reaction mixes for fast and reliable setup. These assays deliver precise and reproducible results, making them an ideal tool for routine diagnostics and surveillance programs.

About BioStone Animal Health — BioStone Animal Health is a Dallas, TX-based biotechnology company that provides innovative solutions for animal health. BioStone Animal Health works together with our worldwide partners to offer a portfolio of animal disease diagnostic products as well as test kits and reagents for vaccine testing that enables performing a rapid evaluation of the efficacies, stability, consistency, and potency of common animal vaccines. By making these test kits available to the international community, BioStone strives to actively promote and participate in global animal health initiatives. For more information about BioStone Animal Health, visit www.biostoneah.com